Distinct immunologic kinetics and cytomegalovirus reactivation incidence with rituximab- versus obinutuzumab–bendamustine in follicular lymphoma: a single-center case series study

Abstract Rituximab and obinutuzumab, anti-CD20 monoclonal antibodies, are widely employed for treatment of follicular lymphoma (FL) by targeting both neoplastic and normal CD20-expressing B lymphocytes, consequently inducing immunosuppression. In this condition, viral reactivations are common and re...

Descrición completa

Detalles Bibliográficos

Principais autores:	Matteo D’Addona, Luca Pezzullo, Lorenzo Settembre, Emilia Vaccaro, Roberto Guariglia, Bianca Serio, Laura Mettivier, Andrea Gigantiello, Giovanni Signorile, Angela Bertolini, Francesca Picone, Bianca Cuffa, Valentina Giudice, Carmine Selleri
Formato:	Artigo
Idioma:	Inglês
Publicado:	Springer 2025-11-01
Series:	Journal of Cancer Research and Clinical Oncology
Assuntos:	Cytomegalovirus Follicular lymphomas Immune reconstitution Viral reactivation Anti-CD20 monoclonal antibodies
Acceso en liña:	https://doi.org/10.1007/s00432-025-06351-2
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!